...
>Collate PK and other data from additional Ab molecules and fit these into proposed 'quality tiers'
>Once we identify T3 data - can we use internal data to move this to T1 or T2?
>Once we have identified molecules in each Tier can we characterise these from a biophysical perspective and see whether there are correlations between PK and early data
Further needs:
-Discussion on sources of data e.g. Jain et al., (2017) publication, FDA drug approval packages
...